Compare
CVS Health Corp vs Guardian Pharmacy Services, Inc. vs PetMed Express Inc vs Ridgetech Inc.
| Latest fiscal year | CVS Health Corp CVS | Guardian Pharmacy Services, Inc. GRDN | PetMed Express Inc PETS | Ridgetech Inc. RDGT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-03-31 | 2026-03-31 |
| Revenue | $402.07B | $1.45B | $179.02M | $132.16M |
| Revenue growth (YoY) | +7.8% | +17.9% | -21.1% | +10.2% |
| Gross margin | n/a | 20.2% | 28.1% | 3.6% |
| Operating margin | 1.2% | 5.0% | -32.8% | -1.4% |
| Net margin | 0.4% | 3.4% | -32.0% | -0.9% |
| Net income | $1.73B | $49.22M | -$57.29M | -$1.25M |
| EPS (Diluted) | $1.39 | n/a | -$2.74 | -$17.21 |
| Operating cash flow | $10.64B | $100.25M | -$28.39M | -$1.39M |
| Free cash flow | $7.81B | $86.84M | -$33.01M | -$1.39M |
| Cash & equivalents | $8.45B | $65.62M | $21.41M | $17.91M |
| Total assets | $253.54B | $412.66M | $81.19M | $69.03M |
| Total liabilities | $178.16B | $194.73M | $52.25M | $28.25M |
| Shareholders' equity | $75.21B | $217.92M | $28.94M | $40.78M |
| Return on year-end equity | 2.3% | 22.6% | -197.9% | -3.1% |
| Shares outstanding | 1.27B | n/a | 21.39M | 887.3K |
Revenue, most recent five fiscal years
| Fiscal year | CVS Health Corp | Guardian Pharmacy Services, Inc. | PetMed Express Inc | Ridgetech Inc. |
|---|---|---|---|---|
| Latest | $402.07B Ended 2025-12-31 | $1.45B Ended 2025-12-31 | $179.02M Ended 2026-03-31 | $132.16M Ended 2026-03-31 |
| 1 year earlier | $372.81B Ended 2024-12-31 | $1.23B Ended 2024-12-31 | $226.97M Ended 2025-03-31 | $119.97M Ended 2025-03-31 |
| 2 years earlier | $357.78B Ended 2023-12-31 | n/a | $274.10M Ended 2024-03-31 | $123.99M Ended 2024-03-31 |
| 3 years earlier | $322.47B Ended 2022-12-31 | n/a | $247.57M Ended 2023-03-31 | $120.20M Ended 2023-03-31 |
| 4 years earlier | $292.11B Ended 2021-12-31 | n/a | n/a | $164.39M Ended 2022-03-31 |